Quote:
Originally Posted by PhillyPDX
Not sure where to place this, but from my friends in the Philly bio tech industry, there has been a serious drop in private funding for research the last 2 years. These layoffs (below) were like 25% of the company's payroll, and according to my friends, are due to an issue many firms in UC are dealing with. I wonder if this is just the tip of the iceberg for a reduction in medical research funds, and what that will due to potential for future growth in UC over the next few years. I'm assuming just another area high interest/loan rates are rearing their ugly heads.
https://www.inquirer.com/health/univ...-20231205.html
|
Yeah, the funding drop is definitely reverberating across the industry:
https://www.forbes.com/sites/ritanum...harmas-future/
It's fallout for sure that's related to interest rates and dramatic pullback in VC. I think it's likely to begin thawing next year, but part of it is an industry model that has to be examined.
But Philly companies tend to be more financially conservative and careful generally. The promising research is still there and is well-positioned to weather the storm.